A research team has investigated the mode of action of a new class of antibiotics that is highly effective against multidrug-resistant pathogens. The so-called fibupeptides impair the energy supply to the bacterial cell, consequently causing their death.
Click here for original story, Antibiotic produced by the microbiome kills bacteria by disturbing energy metabolism
Source: ScienceDaily